Hide Board Information

Show Board Information

Cannondale Corp BIKEQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/06/2014 2:51:22 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

Cannondale Corp (OTCMRKTS: BIKEQ) Stock Message Board

1. BIKEQ Company Profile

    

2. BIKEQ Time & Sales

    

3. BIKEQ Recent News

    

4. BIKEQ Filings

    

5. BIKEQ Financials

    

6. BIKEQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	BIKEQ 0.0005 Stock Charts $BIKEQ 1 Month Chart	chartguy89	03/06/2014 2:51:22 AM
1	BIKEQ Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 8:26:15 AM

Recent Articles

• Ascentage Pharma's Innovative Treatment: A New Hope in Oncology
• Harnessing Xi Jinping's Economic Thought for China's Growth
• Investing in Next-Gen Mpox Detection Testing: GHIT Fund's Role
• Innovent Biologics' Groundbreaking First-in-Human Study Unveiled
• Hydron Energy Innovations in Carbon-Negative Xenon Production
• Skyline Digital Marketing's Unique Method for Business Growth
• Reviving Heritage: The Digital Transformation of Dunhuang Caves
• CARsgen's Innovative CT0596 Therapy Shows Promise in Trials
• HUTCHMED Expands Coverage of Innovative Drugs in China
• ChemLex Secures $45M to Revolutionize Drug Discovery Tech
• ElevenLabs Innovates Hollywood: AI Voice Cloning Revolution
• How Avantor, Inc. Investors Can Take Action on Losses
• Mitsubishi Electric Joins Linux Foundation As Gold Member
• Respiree's AI Software Gains HSA Approval for Patient Monitoring
• ChemLex Secures $45 Million to Revolutionize Drug Discovery
• ALLUONE Introduces Innovative Smart Garden for Urban Homes
• Exploring Open Source in Japan: Opportunities and Challenges
• ChemLex Secures $45 Million Overhaul for Drug Discovery Lab
• CarMax, Inc. Investors Urged to Join Class Action Lawsuit
• Immix Biopharma Achieves Landmark Phase 2 Success with NXC-201
• Immix Biopharma's Strategic $100 Million Stock Offering Explained
• Structure Therapeutics Unveils Upcoming Data from ACCESS Program
• Crypto’s ETF Wave and The New Investment Gateway Beyond Bitcoin
• Matthews International Strategically Navigates Market Challenges
• Positive Results from SELLAS Life Sciences' SLS009 Phase 2 Study
• BeOne Medicines Celebrates Progress of Sonrotoclax in CLL Treatment
• Investors Rally: Join Class Action Against James Hardie Industries
• Transforming Crypto Trading: Anchorage Digital's Partnership
• ImCheck Showcases Promising Efficacy of ICT01 in AML Trials
• Lime & Lemon Apex: A Game-Changer in Collective Dining
• Exciting Developments in Chibougamau Copper-Gold Project
• Analyzing China's Military Advancements and Global Impact
• Rosen Law Firm Investigates Potential Claims for Aglion Health Investors
• Lyell Immunopharma Unlocks Promising Results for Ronde-Cel
• Lynozyfic™ Shows Potential as Frontline Treatment for Myeloma
• Promising Results in Lyell Immunopharma's Ronde-Cel Trial
• Eli Lilly's Jaypirca Achieves Key Milestone in Latest Study
• How Leading Tech Companies Maintain Dominance with Automation
• Wave Life Sciences Set to Reveal Key Trial Data for Obesity
• Embracing Work-Life Balance: A Shift in Employee Priorities
• Power of Attorney Attestation Dubai: Legal Use Cases and Process Guide
• Transforming Investor Mindsets: The Power of Just $1
• Hidden Project Risks That Can Ruin Your Timeline and How To Prevent Them
• Apple Facing Leadership Changes Amid AI Development Concerns
• Elderly Victim's Heartbreaking Loss in Crypto ATM Scam
• Replicor's Innovative Approach to Treating HBV and HDV Infections
• Sundar Pichai on AI Revolutionizing Decisions from Finance to Health
• Prologis to Redeem 3.00% Notes Ahead of 2026 Maturity
• Prologis to Redeem Outstanding Bonds Ahead of Schedule
• Exploring the Sinister Connections of Russian Cyber Attacks